Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
Tags Biotechnology LILLY DRN Zealand Pharma A/S
From CNBC.com News
Ozempic underworld: Inside the black market of obesity drugs
Tags World News Business Health & Science
From CNBC.com News
CNBC Daily Open: October’s gravity bringing stocks down
Tickers JOBS OIL
Tags Europe Markets World Markets NVIDIA Corp
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Alibaba Group Holding Ltd Novo Nordisk A/S JPMorgan Chase & Co
From CNBC.com News
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
Tags Air Freight and Logistics Labor Unions ICU Medical Inc
From CNBC.com News
East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
Tags Strikes US Economy U/S/ Economy
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
Tags Health care industry Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Wednesday
Tags NVIDIA Corp Business Investing
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
Tags Biotechnology Business Companies
From CNBC.com News
Tuesday's big stock stories: What's likely to move the market in the next trading session
Tags United States Steel Corp OREILLY AUT DRN Century Communities Inc
From CNBC.com News
Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100
Tickers NEWS NVO
Tags Zain Rizvi Diabetes Novo Nordisk
From Benzinga
FTC sues drug middlemen for allegedly inflating insulin prices
Tags Sanofi SA Health care industry CVS Health Corp
From CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
Tags Health & Science Biotechnology Eli Lilly and Co
From CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Roche Holding AG
From CNBC.com News
How the Research Triangle has helped make North Carolina one of America's fastest-growing economies
Tags Technology Consumer Staples Scientific research
From CNBC.com News
CNBC Daily Open: All key data is in — and it's made the Fed's policy path more uncertain
Tickers JOBS
Tags Roche Holding AG Interest Rates Daily Open
From CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
Tags Health care industry Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
Tags Healthy Returns Apple Inc Health & Science
From CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
Tags Healthy Returns Social issues Abbott Laboratories
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Technology Business News Novo Nordisk A/S
From CNBC.com News
Weight loss drugs cut Covid-19 deaths, study finds
Tags Breaking News: Markets Business News Novo Nordisk A/S
From CNBC.com News
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
Tags Health & Science Biotechnology Business
From CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
Tags Science US: News Eli Lilly and Co
From CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
Tags Politics Companies Social issues
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags US: News Eli Lilly and Co Bristol/Myers Squibb Co
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Healthy Returns Health & Science Eli Lilly and Co
From CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Tags Companies Breaking news Health care industry
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Tags Health care industry Breaking news Companies
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.